India's Biocon secures approval use drug on coronavirus patientsIndia’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.

India’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.http://feeds.foxbusiness.com/~r/foxbusiness/latest/~3/-Mqa8HriJ5A/indias-biocon-secures-approval-use-drug-on-coronavirus-patients